Adage Capital Partners
BNTC icon

Adage Capital Partners’s Benitec Biopharma BNTC Stock Holding History

Adage Capital Partners’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.4M Hold
2,120,672
– – 0.04% 406
2026
Q1 		$22.6M Hold
2,120,672
– – 0.03% 436
2025
Q4 		$28.6M Buy
2,120,672
+148,148
+8% +$2.05M 0.04% 385
2025
Q3 		$27.7M Hold
1,972,524
– – 0.04% 382
2025
Q2 		$23.1M Hold
1,972,524
– – 0.04% 409
2025
Q1 		$25.7M Hold
1,972,524
– – 0.05% 363
2024
Q4 		$24.9M Buy
1,972,524
+1,131,129
+134% +$12.2M 0.04% 382
2024
Q3 		$7.73M Hold
841,395
– – 0.01% 666
2024
Q2 		$5.88M Buy
841,395
+652,207
+345% +$4.81M 0.01% 692
2024
Q1 		$993K Hold
189,188
– – ﹤0.01% 794
2023
Q4 		$611K Hold
189,188
– – ﹤0.01% 778
2023
Q3 		$572K Buy
+189,188
New +$588K ﹤0.01% 776

Other funds holding BNTC

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Adage Capital Partners's BNTC Position: Q2 2026 in Review

Adage Capital Partners held its Benitec Biopharma (BNTC) position steady in Q2 2026 at 2,120,672 shares worth $28.4M. The position accounts for 0.04% of the portfolio, ranked #406.

Adage Capital Partners first reported a position in BNTC in Q3 2023 and has held it in 12 quarters since. The position peaked at $28.6M in Q4 2025. 87 funds tracked by Wall St. Rank hold BNTC as of Q2 2026.

  • Adage Capital Partners held 2,120,672 shares of Benitec Biopharma worth $28.4M as of Q2 2026.
  • Adage Capital Partners left its Benitec Biopharma share count unchanged in Q2 2026.
  • Benitec Biopharma made up 0.04% of Adage Capital Partners's portfolio in Q2 2026, its #406 holding.
  • Adage Capital Partners first reported a position in Benitec Biopharma in Q3 2023 and has held it in 12 quarters since.
  • Adage Capital Partners's Benitec Biopharma position peaked at $28.6M in Q4 2025.
  • 87 funds tracked by Wall St. Rank held Benitec Biopharma as of Q2 2026.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.